[1] Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of quinazoline alkaloids-related sinusoidal obstruction syndrome(2017, Nanjing)[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2017, 33(9): 1627-1637. [2] DALLE JH, GIRALT SA.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment[J]. Biol Blood Marrow Transplant, 2016, 22(3):400-9. [3] ZHANG F, ZHOU Y, YANG X, et al.Gynura rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors[J]. Acta Pharmacological Sinina, 2019, 40(6): 781-789. [4] ZHU C, REN XH, LIU D, et al.Oxaliplatin-induced hepatic sinusoidal obstruction syndrome[J]. Toxicology, 2021,460: 152882. [5] ZHUGE YZ, WANG X.Hepatic sinusoidal obstruction syndrome associated with pyrrolizidine alkaloids[J]. Journal of Practical Hepatology(实用肝脏病杂志), 2021, 24(5): 617-620. [6] ZHU C, REN XH, LIU D, et al.Oxaliplatin-induced hepatic sinusoidal obstruction syndrome[J]. Toxicology, 2021, 460: 152882. [7] PAUL VS, MATTHEW PL, BALJENDRA K, et al.Transjugular intrahepatic portosystemic shunt complications: prevention and management[J]. Seminars in Interventional Radiology, 2015, 32(2): 123-132. [8] KOLACZKOWSKA E, JENNE CN, SUREWAARD BGJ, et al.Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature[J]. Nature Communications, 2015, 6: 6673. [9] HUANG H, TOHME S, AL-KHAFAJI AB, et al.DAMPs-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury[J]. Hepatology, 2016, 62(2): 600-614. [10] HILSCHER MB, SEHRAWAT T, VERDUGO JPA, et al.Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension[J]. Gastroenterology, 2019, 157(1): 193-209. [11] KUMAR A, PALEK R, LISKA V.A critical analysis of experimental animal models of sinusoidal obstruction syndrome[J]. Journal of Clinical and Experimental Hepatology, 2019, 9(3): 345-353. [12] YANG MB, RUAN JQ, FU PP, et al.Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity[J]. Chemico-Biological Interactions, 2016, 243: 119-126. [13] DELEVE LD, MCCUSKEY RS, WANG X, et al.Characterization of a reproducible rat model of hepatic veno-occlusive disease[J]. Hepatology, 1999, 29(6): 1779-1791. [14] DU JW, ZHANG JM, CHEN XJ, et al.Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients[J]. Clinics and Research in Hepatology and Gastroenterology, 2022, 46(1): 101697. [15] NARITA M, HATANO E, TAMAKI M, et al.Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver[J]. Journal of Gastroenterology and Hepatology, 2009, 24: 1051-1057. [16] PAPAYANNOPOULOS V.Neutrophil extracellular traps in immunity and disease[J]. Nature Reviews Immunology, 2018, 18: 134-147. [17] SAFFARZADEH M, JUENEMANN C, QUEISSER MA, et al.Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones[J]. Plos One, 2012, 7(2): e32366. [18] NARITA M, HATANO E, IKAI I, et al.A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction[J]. Annals of Surgery, 2009, 249(5): 806-813. [19] STADTMANN A, ZARBOCK A.CXCR2: from bench to bedside[J]. Frontiers in Immunology, 2012, 3: 263. [20] WARNATSCH A, IOANNOU M, WANG Q, et al.Inflammation. neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis[J]. Science, 2015, 349(6245): 316-320. |